$RCM Technologies (RCMT.US)$ It is an American company liste...

The company's main business is specialty healthcare, engineering and information technology, and 90% of the market is in the US.

The gross margin has basically remained around 25.5% over the past 5 years, while the return on net assets rose from 7.5% to 13.6%, then turned a loss of 32.5%, and reversed the loss to 45.6% in 2021.

In the past 5 years, with the exception of the decline in 2019 and 2020, revenue increased 16% overall; with the exception of a slight loss in 2020, operating profit increased 52% in 2021 compared to 2019; net profit grew rapidly in the remaining 4 years except for the loss in 2020.

In 2021, revenue reached 200 million, operating profit of 10 million, and net profit of 11 million.

According to the income statement, there were more than 11 million other expenses in 2020, while in 2021 there were 4.3 million other revenues, mainly focused on write-offs and fixed asset sales, none of which were sustainable subjects. Excluding these two effects, the growth rate is not fast.

Currently, the price-earnings ratio is 17.6, and the price-earnings ratio is 8.6, which is not very attractive.